Differential Gene Expression in Ductal Carcinoma in Situ of the Breast Based on ERBB2 Status

Cancer Control - United States
doi 10.1177/107327481702400117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Identification of Aberrant Gene Expression During Breast Ductal Carcinoma in Situ Progression to Invasive Ductal Carcinoma

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Breast Ductal Carcinoma in Situ

International Journal of Surgical Oncology
SurgeryOncology
2012English

Ductal Carcinoma in Situ of the Breast

Mayo Clinic Proceedings
Medicine
2017English

Ductal Carcinoma in Situ of the Breast

New England Journal of Medicine
Medicine
2004English

Ductal Carcinoma in Situ of the Breast

Oncology Reviews
Cancer ResearchOncology
2009English

Ductal Carcinoma in Situ of the Breast

British Journal of Surgery
Surgery
1997English

The P53 Tumor Suppressor Gene in Ductal Carcinoma in Situ of the Breast

American Journal of Pathology
Forensic MedicinePathology
2000English

Different Distribution of Breast Ductal Carcinoma in Situ, Ductal Carcinoma in Situ With Microinvasion, and Invasion Breast Cancer

World Journal of Surgical Oncology
SurgeryOncology
2012English

Gene Expression Differences Between Ductal Carcinoma in Situ With and Without Progression to Invasive Breast Cancer

American Journal of Pathology
Forensic MedicinePathology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy